Scientists at the University of Surrey in the U.K. say they have developed the first reliable test for diagnosing early prostate cancer.
The scientist have identified a protein called EN-2, which is only produced by prostate cancer cells, the new urine test appears to be the first reliable test for diagnosing early prostate cancer. The new test is vastly superior to the existing PSA blood test, which detects fewer than 40% of cancers and has a false positive rate of over 50%.
According to Tim Sharp, a trustee of the Prostate Project, early treatment of prostate cancer is the key to successful treatment. If you catch it early there is an 80% chance of a cure, if you catch it late, that drops to 20%.
The scientists hope the EN-2 test could be in widespread use in 12 to 18 months’ time.
Prostate cancer is cancer that forms in tissues of the prostate. It is the most common cause of death in men over 70 and third most common cause of death from cancer in men of all ages.
According to the National Cancer Institute, in 2010 there were 217,730 new cases of prostate cancer in the U.S., and more than 32,000 deaths.
People who are at higher risk include:
Other people at risk include:
The symptoms listed below can occur with prostate cancer (Most of the time these symptoms are caused by other prostate problems that are not cancer):
For more information on prostate cancer screening, testing, treatments, and studies, talk with a cancer information specialist at 1-800-4-CANCER (1-800-422-6237), or visit the Web site www.healthfinder.gov and type in the words “prostate cancer.”